Proteocyte Diagnostics
Toronto, Canada
Visit website- Scope lines
- 3
- A2LA certificate
- 1
- Sites in our directory
- 3
What this lab is accredited for
We found no published test standard numbers in this lab’s scope. The full scope as published is below.
Only this lab. Searches the method, matrix and range of each of the 3 scope lines.
A2LA certificate 6423.02 · 3 lines
| Line | Method | Matrix | Range |
|---|---|---|---|
| 1 | - | Formalin Fixed Paraffin Embedded (FFPE) Tissues and Digital Images; FFPE, Digitized ImagesShow page textExtracted from the scope document; tables may not line up. View scope for the original. (A2LA Cert. No. 6423.02) 07/22/2025 Page 1 of 1
SCOPE OF ACCREDITATION
CLINICAL LABORATORY ACCREDITATION PROGRAM
Proteocyte Diagnostics Inc.
MaRS Centre, South Tower,
101 College Street, Suite 200, O-219
Toronto, Ontario, Canada, M5G 1L7
Kenneth Pritzker Phone: (833)-577-6836
CLINICAL
Valid To: July 31, 2027 Certificate Number: 6423.02
CLIA ID: 99D2275002
In recognition of the successful completion of the A2LA evaluation to the A2LA Platinum Choice Program (CLIA and ISO
15189:2022), accreditation is granted to this laboratory to perform the following types of testing on human samples, including:
Formalin Fixed Paraffin Embedded (FFPE) Tissues and Digital Images.
Specialty Sub Specialty Test/Analyte Method Matrices
Pathology
Histopathology
Straticyte (S100A7) Risk Assessment
Using Digital Image
Analysis
FFPE,
Digitized
Images | - |
| 2 | Extracted from the scope document; tables may not line up. View scope for the original. For the tests to which this accreditation applies, please refer to the laboratory’s Clinical Scope of Accreditation.
Accredited Laboratory
A2LA has accredited
PROTEOCYTE DIAGNOSTICS INC.
Toronto, CANADA
for technical competence in the field of
Clinical Testing
This laboratory is accredited in accordance with the recognized International
Standard ISO 15189:2022 Medical laboratories – Requirements for quality and competence. This
accreditation demonstrates technical competence for a defined scope and the operation of a laboratory
quality management system (refer to joint IAF-ILAC-ISO Communiqué dated April 2017).
Presented this 22nd day of July 2025.
_______________________
Mr. Trace McInturff, Vice President, Accreditation Services
For the Accreditation Council
Certificate Number 6423.02
Valid to July 31, 2027 | ||
| 3 | Extracted from the scope document; tables may not line up. View scope for the original. A Better World Through Accreditation
A2LA has accredited
PROTEOCYTE DIAGNOSTICS INC.
Toronto, Ontario, CANADA
for technical competence in the field of
Clinical
This laboratory is accredited in accordance with the requirements of the
A2LA’s Laboratory Accreditation Program (CLIA ID Number: 99D2275002). This
accreditation demonstrates technical competence for a defined scope.
Presented this 22nd day of July 2025.
__________________
Mr. Trace McInturff, Vice President, Accreditation Services
For the Accreditation Council
A2LA Certificate Number 6423.02
Valid to July 31, 2027
For the tests to which this accreditation applies,
Please refer to the laboratory’s Clinical Scope of Accreditation. | ||
Ranges are reproduced from the accredited scope document as published, and only where we found that range printed in the document for the line. Otherwise the cell reads “See scope document”. An absent range means the register did not state one. Line numbers are ours, for cross-reference; they follow the order of the scope document.
Other Locations
2 other sites in this organization
Accreditation data refreshed from the A2LA register on .
This page mirrors a public register. For a purchasing, audit or regulatory decision, confirm against the A2LA entry linked above.